Zeotropic mixture harmful effects that hydrochlorofluorocarbons (HCFC) and chlorofluorocarbons (CFC) have on the ozone layer and global warming. Researchers have focused on using new mixtures that have the same properties as past refrigerants to phase out harmful halogenated substances, in accordance to the Montreal Protocol and Kyoto Protocol. For example, researchers found that zeotropic mixture R-404A can replace R-12, a CFC, in household refrigerators. However, there are some technical difficulties for using zeotropic mixtures. This includes leakages, as well as the high temperature glide associated with substances of different boiling points, though the temperature glide can be matched to the temperature difference
Wiley protocol at separate times throughout the period. The protocol is promoted as differing from conventional hormone replacement therapy in several ways: The protocol also includes a follow-up program to monitor the serum of the bioidentical hormones. Wiley has stated that in her opinion, the most important aspect of the protocol is the specific schedule and levels of the hormone doses rather than their bioidentical nature. A patent was granted for the protocol in 2011 for the specific blend of hormones and dosing method. Concerns have been raised that serum levels may not be an acceptable marker for transdermally administered hormones, that